Suchergebnisse - "Beksaç, Meral"

PubPharm (314)

91

HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA

enthalten in: Journal of hematology & oncology | 2021

von Jiang, F. | Tang, X. | Tang, C. | +11

92

HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA

enthalten in: Journal of hematology & oncology | 2021

von Jiang, F. | Tang, X. | Tang, C. | +11

93

Pleural Involvement Upon Relapse of Myeloma Responding to Daratumumab Plus Carfilzomib : A Case Presentation and Literature Review

enthalten in: Clinical lymphoma, myeloma & leukemia | 2021

von Uslu, A. | Seval, G. | Merter, M. | +2

94

Treatment of relapsed and refractory multiple myeloma : recommendations from the International Myeloma Working Group

enthalten in: The Lancet. Oncology | 2021

von Moreau, P. | Kumar, S. | San Miguel, J. | +67

95

Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes in myeloma patients on renal replacement therapy : a report from the Chronic Malignancy Working Party (CMWP) of the European Society of Blood and Marrow Transplantation (EBMT)

enthalten in: Bone marrow transplantation | 2021

von Beksac, M. | Kröger, N. | Byrne, J. | +3

96

A Rare Extramedullary Presentation of Multiple Myeloma : Paraspinal Muscle Involvement Revealed by FDG PET/CT

enthalten in: Turkish journal of haematology : official journal of Turkish Society of Haematology | 2021

von Özkan, E. | Araz, M. | Cengiz Seval, G. | +2

97

Suppression of steroid 5α-reductase type I promotes cellular apoptosis and autophagy via PI3K/Akt/mTOR pathway in multiple myeloma

enthalten in: Cell death & disease | 2021

von Dou, R. | Qian, J. | Wu, W. | +10

98

Efficacy and safety of weekly carfilzomib (70 mg/m2), dexamethasone, and daratumumab (KdD70) is comparable to twice-weekly KdD56 while being a more convenient dosing option : a cross-study comparison of the CANDOR and EQUULEUS studies

enthalten in: Leukemia & lymphoma | 2021

von Leleu, X. | Beksac, M. | Chou, T. | +12

99

Corrigendum : Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma

enthalten in: Frontiers in oncology | 2021

von Chen, Y. | Li, R. | Zhu, Y. | +7

ErratumFor: Front Oncol. 2020 May 15;10:767. - PMID 32500030

100

Recommendations for vaccination in multiple myeloma : a consensus of the European Myeloma Network

enthalten in: Leukemia | 2021

von Ludwig, H. | Boccadoro, M. | Moreau, P. | +29